logo

Quick Facts

Share

Novartis (NVS) said, in early June, the company restarted radioligand therapy production at its sites in Ivrea, Italy, and Millburn, New Jersey, and resumed delivery of doses to patients in a phased approach. Novartis expects that product supply may be initially limited. The company has also restarted...

NeuroSense Therapeutics Ltd. (NRSN) reported results from a biomarker study conducted to evaluate the potential of CogniC, the company's combination drug for the treatment of Alzheimer's disease. The company said the biomarker study identified several biomarkers associated with AD, which indicate CogniC's...

Smith+Nephew (SNN, SN.L) said that the first robotic-assisted surgery using its LEGION CONCELOC Cementless Total Knee System was performed by Cyna Khalily, an orthopaedic surgeon specializing in adult reconstructive surgery of the hip and knee in Louisville, KY. According to the company, LEGION CONCELOC...

Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Thursday that the company may receive up to $20 million from HealthCare Royalty Partners from the sale of its future royalties and sales milestones from Kyowa Kirin Co., Ltd., its collaboration partner in Japan for the commercialization of tenapanor...

Beverage alcohol company Constellation Brands (STZ, STZ.B) announced Thursday that following the recommendation of a special committee comprised solely of independent directors, its Board of Directors has approved, and will recommend to shareholders for approval, a proposal to eliminate the company's...

While reporting financial results for the first quarter of fiscal 2023 on Thursday, beverage alcohol company Constellation Brands, Inc. (STZ) maintained its comparable earnings guidance for the full-year 2023. For fiscal 2023, the company now projects earnings in a range of $10.50 to $10.80 per share...

Blueprint Medicines Corp. (BPMC) announced strategic financing collaborations with Sixth Street and Royalty Pharma (RPRX) for up to $1.25 billion. The company said the financings provide capital to expand and advance its pipeline towards commercialization and to continue pursuing strategic and synergistic...

Pfizer Inc. (PFE) announced Thursday the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for both vaccinated and unvaccinated patients who are at high risk for progression to...

Sanofi (SNY) on Thursday said that the U.S. Food and Drug Administration (FDA) has put partial clinical hold on Phase 3 studies of tolebrutinib in multiple sclerosis (MS) and myasthenia gravis due to some cases of drug-induced liver injury found in patients enrolled in these studies . Consequently,...

Clinical-stage biopharmaceutical company Codiak BioSciences Inc. (CDAK), on Thursday, announced platform-validating clinical data from Phase 1 trials of exoSTINGTM and exoIL-12 and plans to advance both candidates into Phase 2 trials. In an open-label Phase 1 trial, exoIL-12 demonstrated a differentiating...

Acuity Brands, Inc. (AYI) posted third quarter adjusted earnings per share of $3.52, an increase of 27.1 percent from $2.77, prior year. On average, nine analysts polled by Thomson Reuters expected the company to report profit per share of $2.96, for the quarter. Analysts' estimates typically exclude...

Becton, Dickinson and Company (BDX) announced the BD MAX Respiratory Viral Panel, a combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus, has been CE marked to the IVD directive 98/79/EC. The test uses a single nasal swab or a single nasopharyngeal swab sample to find if a...

British drug major AstraZeneca Plc. (AZN.L, AZN) Thursday announced positive high-level results from a planned interim analysis of the AEGEAN Phase III trial that evaluated Imfinzi (durvalumab) plus chemotherapy in resectable non-small cell lung cancer. The company noted that Imfinzi in combination...

International Airlines Group said Thursday that it has converted 14 A320neo family options, announced in August 2013, into firm orders for 11 A320neos and three A321neos. It is in addition to the conversion of eight A320neo family options which IAG exercised in March 2022 for six A320neos and two...

Bunzl plc (BZLFY.PK, BNZL.L) said it expects Group revenue in the first half to increase year-on-year by approximately 16% at actual exchange rates and by 12-13% at constant exchange rates. Group adjusted operating margin for the first half is expected to be slightly higher than historical annual levels,...

Follow RTT